Novartis AG (NVS)
150.44
+1.29
(+0.86%)
USD |
NYSE |
May 19, 16:00
150.49
+0.05
(+0.03%)
After-Hours: 20:00
Novartis Shareholders Equity (Quarterly) : 38.51B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Roche Holding AG | -- |
| AstraZeneca PLC | 47.33B |
| GSK Plc | 23.54B |
| Johnson & Johnson | 81.19B |
| Eli Lilly & Co. | 31.20B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.53B |
| Total Liabilities (Quarterly) | 79.61B |
| Debt to Equity Ratio | 1.220 |
| Current Ratio | 0.8481 |
| Net Debt Paydown Yield | -1.08% |